Imidazole Derivative Synthesis via Ionic Liquid Catalysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a growing need for new antimicrobial agents effective against drug-resistant microorganisms, particularly bacteria and fungi, due to increasing resistance to conventional antibiotics, and existing methods for synthesizing organic compounds often involve hazardous solvents and inefficient processes.
Innovation Solution
The synthesis of 4-(4,5-bis(4-bromophenyl)-2-(4-methoxyphenyl)-1H-imidazol-1-yl)benzoic acid via a one-pot four-component reaction using pyridinium ionic liquid as a catalyst and solvent, which demonstrates excellent antimicrobial activity against various microbes, including gram-positive and gram-negative bacteria, and fungi.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antibiotics are used to treat bacterial infections, then treatment effectiveness is initially good, but microorganisms develop resistance over time
Solution Approach 1:
The patent applies parameter changes by modifying the chemical structure of imidazole compounds through multi-component reactions, creating new derivatives with altered pharmacological properties that can overcome microbial resistance while maintaining therapeutic effectiveness
Solution Approach 2:
The invention creates composite molecular structures by combining multiple components (aldehydes, amines, beta-dicarbonyl compounds, and ammonium salts) into a single imidazole derivative molecule, producing a compound with enhanced and multifaceted antimicrobial activity against resistant strains
2Ease of manufacture
If traditional synthesis methods are used for organic compounds, then synthesis is well-established, but hazardous solvents and inefficient processes are employed
Solution Approach 1:
The patent changes the reaction parameters by employing ionic liquids as solvents and catalysts, which enable the synthesis to proceed under milder conditions with improved yields and reduced environmental harm compared to traditional organic solvents
Solution Approach 2:
The invention uses ionic liquids as an intermediary substance that facilitates the multi-component reaction, providing a green alternative to conventional solvents while enhancing reaction efficiency and product purity through their unique solvation and catalytic properties
3Productivity
If multi-component reactions are performed under conventional conditions, then synthesis is possible, but reaction time is long and yields are lower
Solution Approach 1:
The patent achieves continuous useful action by conducting the multi-component reaction in one pot without isolating intermediate products, allowing the reaction to proceed continuously through all stages to final product formation, thereby reducing overall reaction time and improving efficiency
Solution Approach 2:
The ionic liquid acts as a mediator that enables all four components to react simultaneously in a single reaction vessel, facilitating continuous transformation through intermediate species without requiring separate purification steps, thus dramatically improving productivity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compound exhibits strong antimicrobial activity against Bacillus cereus, Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, Aspergillus flavus, and Chrysosporium keratinophilum, offering a promising therapeutic option for microbial infections while employing a greener, more efficient synthesis method.
Implementation Method 1
Pyridinium ionic liquid as a catalyst
Implementation Method 2
Pyridinium ionic liquid as a catalyst and green solvent
Implementation Method 3
Chemical transformations performed under ultrasound irradiation
Data Source
AI summary
An 4-(4,5-bis(4-bromophenyl)-2-(4-methoxyphenyl)-1H-imidazol-1-yl)benzoic acid compound, its synthesis, and its use as an antimicrobial agent.